《瑞信窝轮》医疗科技股向好，留意平医购21182、里康购21428
内地新型肺炎确诊人数急增，网上诊症股平安好医生（1833）绩後受挫一日後，周四曾回升逾2%，重上74元。看好可考虑平医购21182，行使价83.88元，20年9月到期。阿里系的阿里健康（0241）周四破顶，曾升近半成至14.38元，其後保持在14元靠稳。看好可留意里康购21428，行使价14.08元，20年8月到期。
市场憧憬纸品需求上升，不过近日强势的纸品股维达（3331），周四跌逾1%，但低位仍保持在20元以上。看好可留意轮场上唯一一只维达购21940，行使价22.38元，20年8月到期。
澳门未有新增新型肺炎确诊人数，赌业股周四整固。银河娱乐（0027）窄幅徘徊，低位守在56元以上。看好可留意银河购16858，行使价65.78元，20年10月到期。或银河牛58957，收回价50.68元，行使价49.88元，20年10月到期。相反看淡可留意银河沽21750，行使价44.95元，20年6月到期。
金沙中国（1928）周四靠稳，高位曾升近3%，逼近42元。看好可考虑金沙购20868，行使价51.88元，20年8月到期。或金沙牛60511，收回价33.88元，行使价33.08元，20年7月到期。相反看淡可留意金沙沽21748，行使价33.95元，20年6月到期。
(本结构性产品并无抵押品)
《瑞信香港认股证及牛熊证销售主管何启聪》
免责声明：笔者为瑞士信贷(香港)有限公司的代表 ，并身为证监会持牌人，并无持有相关上市公司的任何财务权益。本文内容仅供参考，并不构成要约、建议或促使任何人士提呈买卖或认购任何证券。结构性产品价格可急升或急跌，投资者或会蒙受全盘损失。本产品并无抵押品。如发行人无力偿债或违约，投资者可能无法收回部份或全部应收款项。牛熊证备强制赎回机制而可能被提早终止，届时(i)N类牛熊证投资者将不获发任何金额；而(ii)R类牛熊证之剩余价值可能为零。有关恒生指数或恒生中国企业指数的免责声明，请参阅上市文件。过往表现并不反映将来表现。投资前，投资者应了解风险，并谘询专业顾问及查阅有关上市文件。瑞信之联属公司为结构性产品之流通量提供者，亦可能是唯一报价者。本文任何内容概不构成投资、法律、会计或税务意见、并无声明任何投资或策略适合或符合阁下的个别情况。结构性产品交投量并不是结构性产品表现的指标，投资者不应仅依赖交投量历史高位数据以厘定结构性产品日後的表现。~重要声明:
以上资讯由第三方提供，AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告，不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料，本公司亦不负品质保证之责任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
